Our subtypes were consistent with the intrinsic breast cancer subtypes (26), including a luminal ER+ luminal A-like group with good prognosis and a cytokeratin-low group previously shown to share features with luminal B tumors (13). This evidence concerns the gene ESR1 and breast cancer.